C-reactive protein and risk of cardiovascular disease: Evidence and clinical application
- 1 September 2003
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 5 (5) , 341-349
- https://doi.org/10.1007/s11883-003-0004-3
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese WomenJAMA, 2003
- C-reactive protein and other inflammatory risk markers in acute coronary syndromesPublished by Elsevier ,2003
- C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial CellsCirculation, 2003
- C-reactive protein and myocardial infarctionJournal of Clinical Epidemiology, 2002
- Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary DeathCirculation, 2002
- Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive ProteinCirculation, 2002
- Effect of Statin Therapy on C-Reactive Protein LevelsJAMA, 2001
- Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary EventsNew England Journal of Medicine, 2001
- C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by MacrophagesCirculation, 2001
- Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart DiseaseNew England Journal of Medicine, 2000